Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L- phenylalanylchloromethyl ketone-sensitive activities

Cancer Research

Volumn 58, Issue 14, 1998, Pages 3066-3072

  Sané, Alain Théophile ^a   Bertrand, Richard ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

20 CAMPTOTHECIN LACTONE; BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; CAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; CYSTEINE PROTEINASE; DNA FRAGMENT; DNA TOPOISOMERASE INHIBITOR; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; DNA DEGRADATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 0032528175     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Wyllie, A. H. The genetic regulation of apoptosis. Curr. Opin. Genet. Dev., 5: 97-104, 1995.
2. White, E. Life, death, and the pursuit of apoptosis. Genes Dev., 10: 1-15, 1996.
3. Jacobson, M. D., Weil, M., and Raff, M. C. Programmed cell death in animal development. Cell, 88: 347-354, 1997.
4. Carson, D. A., and Ribeiro, J. M. Apoptosis and disease. Lancet, 341: 1251-1254, 1993.
5. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
6. Korsmeyer, S. J. Regulators of cell death. Trends Genet., 11: 101-105, 1995.
7. Pantaleo, G., and Fauci, A. Apoptosis in HIV infection. Nat. Med., 1: 118-120, 1995.
8. Stefanis, L., Burke, R. E., and Greene, L. A. Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol., 10: 299-305, 1997.
9. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49: 5870-5878, 1989.
10. Barry, M. A., Behnke, C. A., and Eastman, A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40: 2353-2362, 1990.
11. Bertrand, R., Sarang, M., Jenkin, J., Kerrigan, D., and Pommier, Y. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res., 51: 6280-6285, 1991.
12. Del Bino, G., and Darzynkiewicz, Z. Camptothecin, teniposide, or 4′-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S-phase HL-60 cells. Cancer Res., 51: 1165-1169, 1991.
13. Walker, P. R., Smith, C, Youdale, T., Leblanc, J., Whitfield, J. R, and Sikorska, M. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res., 51: 1078-1085, 1991
14. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis. a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
15. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555-556, 1980.
16. Pandey, S., Walker, P. R., and Sikorska, M. Separate pools of endonuclease activity are responsible for internucleosomal and high molecular mass DNA fragmentation during apoptosis. Biochem. Cell. Biol., 72: 625-629, 1994.
17. Pandey, S., Walker, P. R., and Sikorska, M. Identification of a novel 97 kda endonuclease capable of internucleosomal DNA cleavage. Biochemistry, 36: 711-720, 1997.
18. Alnemri, E. S. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J. Cell. Biochem., 64: 33-42, 1997.
19. Femandes-Alnemri, T., Litwack, G., and Alnemri, E. S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J. Biol. Chem., 269: 30761-30764, 1994.
20. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
21. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L., and Miller, D. K. Identification and inhibition of the Ice/Ced-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
22. Datta, R., Banach, D., Kojima, H., Talanian, R. V., Alnemri, E. S., Wong, W. W., and Kufe, D. W. Activation of the Cpp32 protease in apoptosis induced by 1-β-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood, 88: 1936-1943, 1996.
23. Dubrez, L., Savoy, I., Hamman, A., and Solary, E. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J., 15: 5504-5512, 1996.
24. Martins, L. M., Kottke, T., Mesner, P. W., Basi, G. S., Sinha, S., Frigon, N., Tatar, E., Tung, J. S., Bryant, K., Takahashi, A., Svingen, P. A., Madden, B. J., McCormick, D. J., Earnshaw, W. C., and Kaufmann, S. H. Activation of multiple interleukin-1β converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J. Biol. Chem., 272: 7421-7430, 1997.
25. Macfarlane, M., Cain, K., Sun, X. M., Alnemri, E. S., and Cohen, G. M. Processing/activation of at least four interleukin-1β converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J. Cell Biol., 137: 469-479, 1997.
26. Shimizu, T., and Pommier, Y. Camptothecin-induced apoptosis in P53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases. Leukemia (Baltimore), 11: 1238-1244, 1997.
27. Liu, X. S., Zou, H., Slaughter, C., and Wang, X. D. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell, 89: 175-184, 1997.
28. Bruno, S., Del Bino, G., Lassota, P., Giaretti, W., and Darzynkiewicz, Z. Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes. Leukemia (Baltimore), 6: 1113-1120, 1992.
29. Weaver, V. M., Lach, B., Walker, P. R., and Sikorska, M. Role of proteolysis in apoptosis: involvement of serine proteases in internucleosomal DNA fragmentation in immature thymocytes. Biochem. Cell. Biol., 71: 488-500, 1993.
30. Wright, S. C., Wei, Q. S., Zhong, J., Zheng, H., Kinder, D. H., and Larrick, J. W. Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J. Exp. Med., 180: 2113-2123, 1994.
31. Ghibelli, L., Maresca, V., Coppola, S., and Gualandi, G. Protease inhibitors block apoptosis at intermediate stages: a compared analysis of DNA fragmentation and apoptotic nuclear morphology. FEBS Lett., 377: 9-14, 1995.
32. Yoshida, A., Takauji, R., Inuzuka, M., Ueda, T., and Nakamura, T. Role of serine and ICE-Like proteases in induction of apoptosis by etoposide in human leukemia HL-60 cells. Leukemia (Baltimore), 10: 821-824, 1996.
33. Hara, S. S., Halicka, H. D., Bruno, S., Gong, J. P., Traganos, F., and Darzynkiewicz, Z. Effect of protease inhibitors on early events of apoptosis. Exp. Cell Res., 223: 372-384, 1996.
34. Adjei, P. N., Kaufmann, S. H., Leung, W. Y., Mao, F., and Gores, G. J. Selective induction of apoptosis in Hep 3b cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. J. Clin. Invest., 98: 2588-2596, 1996.
35. Zhu, H., Dinsdale, D., Alnemri, E. S., and Cohen, G. M. Apoptosis in human monocytic THP.1 cells involves several distinct targets of N-tosyl-L-phenylalanyl chloromethyl ketone. Cell Death Differ., 4: 590-599, 1997.
36. Sané, A. T., Schmitt, E., Steyaert, A., Meyer, D., and Bertrand, R. The CrmA- and TPCK-sensitive pathways that trigger the oligonucleosome-sized DNA fragmentation in camptotnecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation. Biochem. Cell. Biol., 75: 359-368, 1997.
37. Miller, S. A., Dykes, D. D., and Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215, 1988.
38. Bertrand, R., Solary, E., O'Connor, P., Kohn, K. W., and Pommier, Y. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211: 314-321, 1994.
39. Solary, E., Bertrand, R., Kohn, K. W., and Pommier, Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood, 81: 1359-1368, 1993.
40. Alnemri, E. S., and Litwack, G. Activation of internucleosomal DNA cleavage in human CEM lymphocytes by glucocorticoid and novobiocin. Evidence for a non-Ca2(+)-requiring mechanism(s). J. Biol. Chem., 265: 17323-17333, 1990.
41. Walker, P. R., and Sikorska, M. Endonuclease activities, chromatin structure, and DNA degradation in apoptosis. Biochem. Cell Biol., 72: 615-623, 1994.
42. Beere, H. M., Chresta, C. M., Alejo-Herberg, A., Skladanowski, A., Dive, C., Larsen, A. K., and Hickman, J. A. Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis. Mol. Pharmacol., 47: 986-996, 1995.
43. Rusnak, J. M., Calmels, T. P. G., Hoyt, D. G., Kondo, Y., Yalowich, J. C., and Lazo, J. S. Genesis of discrete higher order DNA fragments in apoptotic human prostatic carcinoma cells. Mol. Pharmacol., 49: 244-252, 1996.
44. Jacobson, M. D., Weil, M., and Raff, M. C. Role of Ced3/Ice-Family proteases in staurosporine-induced programmed cell death. J. Cell Biol., 133: 1041-1051, 1996.
45. Kumar, S., and Harvey, N. L. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett., 375: 169-173, 1995.
46. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thomberry, N. A., Wong, W. W., and Yuan, J. Human ICE/CED-3 protease nomenclature. Cell, 87: 171, 1996.
47. Patel, T., Gores, G. J-, and Kaufmann, S. H. The role of proteases during apoptosis. FASEB J., 10: 587-597, 1996.
48. Gupta, M., Fujimori, A., and Pommier, Y. Eukaryotic DNA topoisomerase I. Biochim. Biophys. Acta, 1262: 1-14, 1995.
49. Pommier, Y., Leteurtre, F., Fesen, M. R., Fujimori, A., Bertrand, R., Solary, E., Kohlhagen, G., and Kohn, K. W. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest., 12: 530-542, 1994.
50. 2+ is inhibited by a variety of structurally unrelated inhibitors. Biochem. Cell. Biol., 72: 631-638, 1994.
51. 2+ alone. FEBS Lett., 349: 385-391, 1994.
52. Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. A., Hickman, J. A., Wakeling, A. E., Walker, P. R., and Sikorska, M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in absence of internucleosomal fragmentation. EMBO J., 12: 3679-3684, 1993.
53. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (Lond.), 391: 43-50, 1998.
54. Sakahira, H., Enari, M., and Nagata, S. Cleavage of CAD inhibitor in CAD activation, and DNA degradation during apoptosis. Nature (Lond.), 391: 96-99, 1998.
55. Suzuki, A., Iwasaki, M., and Wagai, N. Involvement of cytoplasmic serine proteinase and Cpp32 subfamily in the molecular machinery of caspase 3 activation during Fas-mediated apoptosis. Exp. Cell Res., 233: 48-55, 1997.
56. Wolman, Y., Ladkany, D., and Frankel, M. Synthesis of activated esters of N-protected amino-acids. J. Chem. Soc. Perkin Trans. I, 8: 689-690, 1967.
57. O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., Friend, S., Fomace, A. J., and Kohn, K. W. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 57: 4285-4300, 1997.
58. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821-1828, 1994.
59. Kohn, K. W., Jackman, J., and O'Connor, P. M. Cell cycle control and cancer chemotherapy. J. Cell. Biochem., 54: 440-452, 1994.
60. Kaufmann, W. K., and Paules, R. S. DNA damage and cell cycle checkpoints. FASEB J., 10: 238-247, 1996.